5.50

0.18% 0.010

Immucell Corp (ICCC)

Overview News Price History Financials Discussions Forecast Stock Split

Immucell Corp stock is traded at $5.50, with a volume of 4,087. It is up +0.18% in the last 24 hours and up +10.66% over the past month. ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Previous Close:

$5.49

Open:

$5.55

24h Volume:

4,087

Relative Volume:

0.24

Market Cap:

$49.40M

Revenue:

$23.84M

Net Income/Loss:

$-3.81M

P/E Ratio:

-11.00

EPS:

-0.5

Net Cash Flow:

$-713.00K

1W Performance:

+8.59%

1M Performance:

+10.66%

6M Performance:

+51.72%

1Y Performance:

+8.91%

1-Day Range:

$5.3833

$5.55

1-Week Range:

$5.00

$5.55

52-Week Range:

$3.34

$5.82

Immucell Corp Stock (ICCC) Company Profile

Name

Immucell Corp

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

(207) 878-2770

Address

56 EVERGREEN DR, PORTLAND, ME

Employee

Twitter

Next Earnings Date

2024-11-13

Latest SEC Filings

ICCC's Discussions on Twitter

Compare ICCC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ICCC Immucell Corp	5.50	49.40M	23.84M	-3.81M	-713.00K	-0.50
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

Immucell Corp Stock (ICCC) Latest News

Apr 17, 2025

The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance

Apr 17, 2025

Apr 16, 2025

ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Apr 16, 2025

Apr 08, 2025

ImmuCell reports record sales in first quarter of 2025 - Investing.com

Apr 08, 2025

Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan

Apr 08, 2025

Apr 07, 2025

ImmuCell appoints new CFO to bolster growth strategy - Investing.com

Apr 07, 2025

ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan

Apr 07, 2025

ImmuCell Hires Chief Financial Officer - The Globe and Mail

Apr 07, 2025

Apr 03, 2025

ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance

Apr 03, 2025

Apr 02, 2025

Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan

Apr 02, 2025

Mar 28, 2025

IMMUCELL CORP /DE/ SEC 10-K Report - TradingView

Mar 28, 2025

Mar 26, 2025

ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Mar 26, 2025

Mar 18, 2025

ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World

Mar 18, 2025

Feb 28, 2025

ImmuCell Corp. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval For Re-Tain - Barchart

Feb 28, 2025

Feb 27, 2025